Abstract: The present invention relates to a luminescent particle, ink formulation, polymer composition, optical device and a preparation thereof. The invention further relates to use of a luminescent particle in a medium or biological imaging.
Type:
Application
Filed:
June 29, 2016
Publication date:
August 2, 2018
Applicant:
MERCK PATENT GMBH
Inventors:
Yuki HIRAYAMA, Hiroshi OKURA, Stephan DERTINGER, Yoshio KOBAYASHI
Abstract: Compounds of the formula I, and liquid-crystalline media, preferably having a nematic phase and negative dielectric anisotropy, comprising a) one or more compounds of the formula I and one or more compounds selected from b) one or more compounds of formula II and/or c) one or more compounds selected from compounds of formulae III-1 to III-4 and formula B Methods for making and using these liquid-crystalline media in electro-optical displays, particularly in active-matrix displays based on the VA, ECB, PALC, FFS or IPS effect and the displays which contain these media. Methods for stabilizing liquid-crystalline media with compounds of formula I, where the liquid-crystalline media comprise one or more compounds of the formula II and one or more compounds selected from compounds of the formulae III-1 to III-4 and formula B.
Type:
Application
Filed:
January 30, 2018
Publication date:
August 2, 2018
Applicant:
MERCK PATENT GMBH
Inventors:
Martin ENGEL, Sabrina MAAG, Ingo ALMEROTH, Rocco FORTTE, Achim GOETZ, Thorsten KODEK, Oliver HEPPERT
Abstract: Compounds of formula I, and liquid-crystalline media, preferably having a nematic phase and negative dielectric anisotropy, comprising: a) one or more compounds of formula I and one or more other compounds selected from: b) one or more compounds of formula II and/or c) one or more compounds selected from compounds of formulae III-1 to III-4 and B Use thereof in electro-optical displays, particularly in active-matrix displays based on the VA, ECB, PALC, FFS or IPS effect and use of compounds of formula I for stabilisation of liquid-crystalline media which comprise one or more compounds of formula II and/or one or more compounds selected from compounds of formulae III-1 to III-4 and B.
Type:
Application
Filed:
January 30, 2018
Publication date:
August 2, 2018
Applicant:
Merck Patent GmbH
Inventors:
Martin ENGEL, Sabrina MAAG, Ingo ALMEROTH, Rocco FORTTE, Achim GOETZ, Thorsten KODEK, Oliver HEPPERT
Abstract: The present invention relates to liquid-crystalline media (LC media) having negative or positive dielectric anisotropy, comprising a low-molecular-weight component and a polymerisable component. The polymerisable component comprises self-aligning, polymerisable mesogens (polymerisable self-alignment additives) which effect homeotropic (vertical) alignment of the LC media at a surface or the cell walls of a liquid-crystal display (LC display). The invention therefore also encompasses LC displays having homeotropic alignment of the LC medium without alignment layers. The invention discloses novel structures for polymerisable self-alignment additives which have a certain position of the functional groups.
Type:
Application
Filed:
June 25, 2015
Publication date:
July 26, 2018
Applicant:
MERCK PATENT GMBH
Inventors:
Graziano ARCHETTI, Izumi SAITO, Rocco FORTTE, Oliver HEPPERT, Andreas TAUGERBECK, Elena NEUMANN
Abstract: The invention relates to the use of specific fluorosurfactants for increasing the efficacy of antioxidants, in particular in cosmetic, dermatological preparations and medicinal products, and to specific mixtures and preparations
Abstract: The present invention relates to premixes for the production of active compound-containing tablets which comprise polyvinyl alcohols (PVAs). The invention also relates to active compound-containing tablets which comprise a corresponding premix.
Type:
Application
Filed:
July 3, 2015
Publication date:
July 26, 2018
Applicant:
Merck Patent GmbH
Inventors:
Roberto OGNIBENE, Finn BAUER, Thorsten WEDEL, Guenter MODDELMOG
Abstract: The present application concerns a switchable device for the regulation of light transmission, which has a compartemented structure, where the switching state of each of the compartments can be controlled individually.
Abstract: The present invention relates to boron compounds for use in electronic devices, especially organic electroluminescent devices, and to a process for preparing these compounds and to electronic devices, especially organic electroluminescent devices, comprising these compounds.
Type:
Grant
Filed:
November 26, 2012
Date of Patent:
July 24, 2018
Assignee:
Merck Patent GmbH
Inventors:
Teresa Mujica-Fernaud, Amir Hossain Parham, Philipp Stoessel, Christof Pflumm, Arne Buesing, Thomas Eberle
Abstract: The present application relates to spirobifluorene derivatives of a formula (I), to the use thereof in electronic devices, and to processes for preparing said derivatives.
Type:
Grant
Filed:
January 19, 2016
Date of Patent:
July 24, 2018
Assignee:
Merck Patent GmbH
Inventors:
Jochen Pfister, Teresa Mujica-Fernaud, Elvira Montenegro
Abstract: An optical device, having an active matrix, containing polymer dispersed liquid crystals, guest-host liquid crystals, suspended particles and/or polymer stabilized cholesteric liquid crystals, the active high transmissive mode has at least 40% of incoming light transmitted through the optical device and in low transmissive mode less than 40% of incoming light transmitted through the optical device, the active matrix is switchable between high transmissive mode and low transmissive mode. The optical device containing a fail-safe mechanism, which is capable to switch the active matrix from a low transmissive mode in a high transmissive mode without the power of an applied grid. The optical device has a fail-safe mechanism comprising at least one battery and a controller.
Abstract: The present invention relates to cell culture media comprising inorganic ester derivatives of tyrosine and/or cysteine. The poor solubility of tyrosine and the often non-sufficient stability of cysteine in cell culture media is overcome by substituting them with an inorganic ester derivative, e.g. with a phosphorylated derivative.
Type:
Grant
Filed:
November 14, 2013
Date of Patent:
July 24, 2018
Assignee:
Merck Patent GmbH
Inventors:
Joerg Von Hagen, Marcel Andre Breuning, Christian Jasper
Abstract: The present invention relates to a novel electron transfer composition comprising one or more metal ion comprising compound, the use of such electron transfer composition in organic electronic devices, particularly in photodiodes, as well as such organic electronic devices, particularly photodiodes.
Type:
Grant
Filed:
May 9, 2014
Date of Patent:
July 24, 2018
Assignee:
Merck Patent GmbH
Inventors:
Lichun Chen, Frank Egon Meyer, Andromachi Malandraki, Piotr Wierzchowiec, Tomas Backlund
Abstract: The present invention relates to a method of reducing ODF mura in liquid crystal (LC) displays of the polymer sustained alignment (PSA) type and to PSA LC displays made by this method.
Abstract: The invention relates to novel organic semiconducting compounds containing a polycyclic unit, to methods for their preparation and educts or intermediates used therein, to compositions, polymer blends and formulations containing them, to the use of the compounds, compositions and polymer blends as organic semiconductors in, or for the preparation of, organic electronic (OE) devices, especially organic photovoltaic (OPV) devices, perovskite-based solar cell (PSC) devices, organic photodetectors (OPD), organic field effect transistors (OFET) and organic light emitting diodes (OLED), and to OE, OPV, PSC, OPD, OFET and OLED devices comprising these compounds, compositions or polymer blends.
Type:
Application
Filed:
December 6, 2017
Publication date:
July 12, 2018
Applicant:
MERCK PATENT GMBH
Inventors:
Graham MORSE, Lana NANSON, William MITCHELL, Michal KROMPIEC, Mansoor D'LAVARI, Agnieszka PRON
Abstract: The present invention relates to liquid-crystalline media comprising one or more compounds selected from the compounds of formula I and compounds of formulae CV, OT and CP wherein the occurring groups have the meanings defined herein, and to liquid-crystal displays containing these media, especially to active-matrix displays and in particular to IPS and FFS displays. The invention further relates to a process for the fabrication of liquid crystal displays using the ODF process.
Abstract: The invention relates to compounds of formula I, (R11O)sSi(CH3)3-s-Sp11-NR12-Sp12-C(OR13)tH3-t ??I wherein the parameter are defined in claim 1, a method for their preparation, to the use of compounds of formula I as adhesion promotors in polymerisable liquid crystal (LC) material, to a polymer film comprising a polymerised material with improved adhesion to a substrate, to methods for preparing such a polymer film, to a corresponding polymerisable LC material used for the preparation of such a polymer film, and to the use of the polymer film and said polymerisable LC material for optical, electrooptical, decorative or security uses and devices.
Type:
Application
Filed:
June 6, 2016
Publication date:
July 12, 2018
Applicant:
Merck Patent GmbH
Inventors:
Kevin ADLEM, Iain GARDINER, Jack BRADFORD, Stephen MULCAHY, James ALLEN
Abstract: The present invention relates to a process for the stabilisation of a Liquid crystal (LC) mixture with negative dielectric anisotropy characterised in that one or more stabilisers of formula I Ra-A1-(Z1-A2)m1-Rb ??I in which Ra, Rb, A1, A2, Z1 and m1 have the meanings given in claim 1, are added to the LC mixture in a total amount of ?0.1% based on the total mixture, to an LC medium containing one or more stabilisers of formula I and to an LC display of the VA-, IPS or FFS type comprising said stabilised liquid crystal medium.
Type:
Application
Filed:
May 27, 2016
Publication date:
July 12, 2018
Applicant:
Merck Patent GmbH
Inventors:
Martin ENGEL, Nico JOHN, Rocco FORTTE, Constanze BROCKE
Abstract: The present invention provides novel pyrimidine and pyridine compounds according to Formula (I), Formula (II), Formula (III), Formula (IV) and Formula (V) their manufacture and use for the treatment of hyperproliferative diseases including, but not limited to, cancer, lupus, allergic disorders, Sjogren's disease and rheumatoid arthritis. In preferred embodiments, the present invention describes irreversible kinase inhibitors including, but not limited to, inhibitors of Bruton's tyrosine kinase.
Type:
Grant
Filed:
January 27, 2017
Date of Patent:
July 10, 2018
Assignee:
Merck Patent GmbH
Inventors:
Brian L. Hodous, Lesley Liu-Bujalski, Reinaldo Jones, Donald Bankston, Theresa L. Johnson, Igor Mochalkin, Ngan Nguyen, Hui Qiu, Andreas Goutopoulos, Nadia Brugger
Abstract: Disclosed are dibenzofuran and dibenzothiophene derivatives of the general formula I, in which X1, X2, W, Y, R, A, Z and m have the meaning defined in claim 1, to a process for the preparation thereof, to the use thereof as components in liquid-crystalline media, and to electro-optical display elements which contain the liquid-crystalline media according to the invention.
Type:
Grant
Filed:
April 11, 2016
Date of Patent:
July 10, 2018
Assignee:
MERCK PATENT GMBH
Inventors:
Lars Lietzau, Constanze Brocke, Volker Reiffenrath, Atsutaka Manabe